357 related articles for article (PubMed ID: 28076849)
41. Metabolomic profile of children with recurrent respiratory infections.
Bozzetto S; Pirillo P; Carraro S; Berardi M; Cesca L; Stocchero M; Giordano G; Zanconato S; Baraldi E
Pharmacol Res; 2017 Jan; 115():162-167. PubMed ID: 27888158
[TBL] [Abstract][Full Text] [Related]
42. An integrative approach based on GC-qMS and NMR metabolomics data as a comprehensive strategy to search potential breast cancer biomarkers.
Silva CL; Perestrelo R; Capelinha F; Tomás H; Câmara JS
Metabolomics; 2021 Aug; 17(8):72. PubMed ID: 34389918
[TBL] [Abstract][Full Text] [Related]
43. Integrative Pathway Analysis of Metabolic Signature in Bladder Cancer: A Linkage to The Cancer Genome Atlas Project and Prediction of Survival.
von Rundstedt FC; Rajapakshe K; Ma J; Arnold JM; Gohlke J; Putluri V; Krishnapuram R; Piyarathna DB; Lotan Y; Gödde D; Roth S; Störkel S; Levitt JM; Michailidis G; Sreekumar A; Lerner SP; Coarfa C; Putluri N
J Urol; 2016 Jun; 195(6):1911-9. PubMed ID: 26802582
[TBL] [Abstract][Full Text] [Related]
44. [Gastroenterological Cancer Diagnosis by Metabolomics-Discovery of Pancreatic Cancer Biomarker].
Yoshida M; Nishiumi S; Azuma T
Rinsho Byori; 2015 Apr; 63(4):450-6. PubMed ID: 26536778
[TBL] [Abstract][Full Text] [Related]
45. Plasma metabolome analysis by integrated ionization rapid-resolution liquid chromatography/tandem mass spectrometry.
Tian H; Bai J; An Z; Chen Y; Zhang R; He J; Bi X; Song Y; Abliz Z
Rapid Commun Mass Spectrom; 2013 Sep; 27(18):2071-80. PubMed ID: 23943328
[TBL] [Abstract][Full Text] [Related]
46. [Metabolomics for Biomarker Discovery in Systemic Lupus Erythematosus].
Saegusa J; Kawano S; Morinobu A
Rinsho Byori; 2015 Apr; 63(4):498-505. PubMed ID: 26536784
[TBL] [Abstract][Full Text] [Related]
47. Metabolic Footprinting of a Clear Cell Renal Cell Carcinoma in Vitro Model for Human Kidney Cancer Detection.
Knott ME; Manzi M; Zabalegui N; Salazar MO; Puricelli LI; Monge ME
J Proteome Res; 2018 Nov; 17(11):3877-3888. PubMed ID: 30260228
[TBL] [Abstract][Full Text] [Related]
48. Secondary electrospray ionization-mass spectrometry and a novel statistical bioinformatic approach identifies a cancer-related profile in exhaled breath of breast cancer patients: a pilot study.
Martinez-Lozano Sinues P; Landoni E; Miceli R; Dibari VF; Dugo M; Agresti R; Tagliabue E; Cristoni S; Orlandi R
J Breath Res; 2015 Sep; 9(3):031001. PubMed ID: 26390050
[TBL] [Abstract][Full Text] [Related]
49. Development of a universal metabolome-standard method for long-term LC-MS metabolome profiling and its application for bladder cancer urine-metabolite-biomarker discovery.
Peng J; Chen YT; Chen CL; Li L
Anal Chem; 2014 Jul; 86(13):6540-7. PubMed ID: 24877652
[TBL] [Abstract][Full Text] [Related]
50. Metabolomic serum profiling detects early-stage high-grade serous ovarian cancer in a mouse model.
Jones CM; Monge ME; Kim J; Matzuk MM; Fernández FM
J Proteome Res; 2015 Feb; 14(2):917-27. PubMed ID: 25567202
[TBL] [Abstract][Full Text] [Related]
51. Serum metabolomics as a novel diagnostic approach for gastrointestinal cancer.
Ikeda A; Nishiumi S; Shinohara M; Yoshie T; Hatano N; Okuno T; Bamba T; Fukusaki E; Takenawa T; Azuma T; Yoshida M
Biomed Chromatogr; 2012 May; 26(5):548-58. PubMed ID: 21773981
[TBL] [Abstract][Full Text] [Related]
52. Development and Validation of a Novel Plasma Protein Signature for Breast Cancer Diagnosis by Using Multiple Reaction Monitoring-based Mass Spectrometry.
Lee HB; Kang UB; Moon HG; Lee J; Lee KM; Yi M; Park YS; Lee JW; Yu JH; Choi SH; Cho SH; Lee C; Han W; Noh DY
Anticancer Res; 2015 Nov; 35(11):6271-9. PubMed ID: 26504062
[TBL] [Abstract][Full Text] [Related]
53. [Analysis of serum metabonome of patients with breast cancer by gas chromatography-mass spectrometry].
Wang J; Yu LF; Shen P; Wang SF
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2009 Sep; 38(5):478-84. PubMed ID: 19830860
[TBL] [Abstract][Full Text] [Related]
54. Metabolomic Analysis Using Liquid Chromatography/Mass Spectrometry for Gastric Cancer.
Liang Q; Wang C; Li B
Appl Biochem Biotechnol; 2015 Aug; 176(8):2170-84. PubMed ID: 26088916
[TBL] [Abstract][Full Text] [Related]
55. Metabolomic Profiling of Blood-Derived Microvesicles in Breast Cancer Patients.
Buentzel J; Klemp HG; Kraetzner R; Schulz M; Dihazi GH; Streit F; Bleckmann A; Menck K; Wlochowitz D; Binder C
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948336
[TBL] [Abstract][Full Text] [Related]
56. Novel serum metabolomics-based approach by gas chromatography/triple quadrupole mass spectrometry for detection of human skin cancers: Candidate biomarkers.
Fukumoto T; Nishiumi S; Fujiwara S; Yoshida M; Nishigori C
J Dermatol; 2017 Nov; 44(11):1268-1275. PubMed ID: 28593747
[TBL] [Abstract][Full Text] [Related]
57. Metabolomics in Breast Cancer: Current Status and Perspectives.
Hart CD; Tenori L; Luchinat C; Di Leo A
Adv Exp Med Biol; 2016; 882():217-34. PubMed ID: 26987537
[TBL] [Abstract][Full Text] [Related]
58. Postprandial metabolomics: A pilot mass spectrometry and NMR study of the human plasma metabolome in response to a challenge meal.
Karimpour M; Surowiec I; Wu J; Gouveia-Figueira S; Pinto R; Trygg J; Zivkovic AM; Nording ML
Anal Chim Acta; 2016 Feb; 908():121-31. PubMed ID: 26826694
[TBL] [Abstract][Full Text] [Related]
59. Novel personalized pathway-based metabolomics models reveal key metabolic pathways for breast cancer diagnosis.
Huang S; Chong N; Lewis NE; Jia W; Xie G; Garmire LX
Genome Med; 2016 Mar; 8(1):34. PubMed ID: 27036109
[TBL] [Abstract][Full Text] [Related]
60. Metabolite marker discovery for the detection of bladder cancer by comparative metabolomics.
Shao CH; Chen CL; Lin JY; Chen CJ; Fu SH; Chen YT; Chang YS; Yu JS; Tsui KH; Juo CG; Wu KP
Oncotarget; 2017 Jun; 8(24):38802-38810. PubMed ID: 28415579
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
